14.9 C
New York
Friday, May 3, 2024

Valeant Plunges On BBG Report Former CEO, CFO Are Focus Of Criminal Probe For Accounting Fraud

Courtesy of ZeroHedge. View original post here.

While details are still lacking, moments ago Valeant stock plunged on a Bloomberg report that the Ex-CEO and ex-CFO are the target of a criminal probe due to accounting fraud.

According to Bloomberg, U.S. prosecutors are focusing on Valeant Pharmaceuticals’ former CEO and CFO as they build a fraud case against the company that could yield charges within weeks, according to people familiar with the matter, Bloomberg News reports.

On the news, VRX stock, which has had many aborted attempts to break solidly above the $20 level, just got dragged back in the teens.

Developing.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,281FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x